{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:41:57Z","timestamp":1788990117886,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21 K09284"],"award-info":[{"award-number":["21 K09284"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24 K11602"],"award-info":[{"award-number":["24 K11602"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bonr.2025.101886","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:06:09Z","timestamp":1762783569000},"page":"101886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Distinct osteoclastogenic potential of granulocyte-macrophage colony-stimulating factor-induced monocyte subsets"],"prefix":"10.1016","volume":"27","author":[{"given":"Shiho","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2025.101886_bb0005","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V88.10.4029.bloodjournal88104029","article-title":"Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes","volume":"88","author":"Akagawa","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bonr.2025.101886_bb0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"Behrens","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bonr.2025.101886_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/1478-6354-13-S1-S3","article-title":"Understanding emerging treatment paradigms in rheumatoid arthritis","volume":"13","author":"Breedveld","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bonr.2025.101886_bb0020","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/annrheumdis-2012-202450","article-title":"Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bonr.2025.101886_bb0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/360258a0","article-title":"GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells","volume":"360","author":"Caux","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bonr.2025.101886_bb0030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41590-019-0526-7","article-title":"Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1","volume":"20","author":"Hasegawa","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bonr.2025.101886_bb0035","first-page":"318","article-title":"The mechanism of action of tofacitinib\u2014an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis","volume":"34","author":"Hodge","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bonr.2025.101886_bb0040","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.179.3.1449","article-title":"TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses","volume":"179","author":"Iwamoto","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bonr.2025.101886_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtla.2024.102166","article-title":"Suppression of bone resorption in ovariectomized mice using estrogen-immobilized polyphosphodiesters","volume":"36","author":"Iwasaki","year":"2024","journal-title":"Materialia"},{"key":"10.1016\/j.bonr.2025.101886_bb0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2025.101886_bb0055","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/ar2046","article-title":"Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts","volume":"8","author":"Komano","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bonr.2025.101886_bb0060","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/endo.136.6.7750457","article-title":"Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages","volume":"136","author":"Lacey","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2025.101886_bb0065","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1182\/blood.V96.13.4335","article-title":"An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand","volume":"96","author":"Miyamoto","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bonr.2025.101886_bb0070","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood-2002-11-3437","article-title":"IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL","volume":"102","author":"Moreno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bonr.2025.101886_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115616","article-title":"Human dendritic cell-derived osteoclasts with high bone resorption capacity and T cell stimulation ability","volume":"142","author":"Narisawa","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2025.101886_bb0080","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.39837","article-title":"RANK-independent osteoclast formation and bone erosion in inflammatory arthritis","volume":"68","author":"O\u2019Brien","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2025.101886_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115887","article-title":"Bisphosphonates in inflammatory rheumatic diseases","volume":"146","author":"Peris","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2025.101886_bb0090","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bonr.2025.101886_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","article-title":"Bone loss in rheumatoid arthritis: basic mechanisms and clinical implications","volume":"102","author":"Shim","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2025.101886_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009749609082660","article-title":"The role of T-lymphocytes and cytokines in rheumatoid arthritis","volume":"25","author":"Smolen","year":"1996","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bonr.2025.101886_bb0105","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bonr.2025.101886_bb0110","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1136\/ard-2023-224449","article-title":"Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)","volume":"82","author":"Taylor","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bonr.2025.101886_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00774-003-0439-1","article-title":"The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis","volume":"21","author":"Udagawa","year":"2003","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2025.101886_bb0120","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bonr.2025.101886_bb0125","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/ard.2007.080341","article-title":"Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis","volume":"67","author":"Yamada","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bonr.2025.101886_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40364-024-00695-6","article-title":"GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment","volume":"12","author":"Yamamichi","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bonr.2025.101886_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bonr.2025.101886_bb0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.38218","article-title":"Combination of tumor necrosis factor \u03b1 and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo","volume":"66","author":"Yokota","year":"2014","journal-title":"Arthritis Rheum."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:09:06Z","timestamp":1778872146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187225000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S2352187225000634"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101886","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct osteoclastogenic potential of granulocyte-macrophage colony-stimulating factor-induced monocyte subsets","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101886"}}